WARNING: This product is for research use only, not for human or veterinary use.
Hodoodo CAT#: H124900
CAS#: 149930-93-8 (sulfate)
Description: Arfolitixorin is an antifolate modulator drug candidate.
Hodoodo Cat#: H124900
Name: Arfolitixorin monosulfate
CAS#: 149930-93-8 (sulfate)
Chemical Formula: C20H25N7O10S
Exact Mass: 555.14
Molecular Weight: 555.520
Elemental Analysis: C, 43.24; H, 4.54; N, 17.65; O, 28.80; S, 5.77
This product is not in stock, which may be available by custom synthesis.
For cost-effective reason, minimum order is 1g (price is usually high, lead time is 2~3 months, depending on the technical challenge).
Quote less than 1g will not be provided. To request quote, please email to sales @hodoodo.com or click below button.
Note: Price will be listed if it is available in the future.
Related CAS #: 31690-11-6 (free) 149930-93-8 (sulfate) 154705-24-5 (sodium)
Synonym: Arfolitixorin monosulfate; PO4XPF4TIX; UNII-PO4XPF4TIX; 149930-93-8
IUPAC/Chemical Name: (2S)-2-[[4-[(6aR)-3-amino-1-oxo-2,5,6,6a,7,9-hexahydroimidazo[1,5-f]pteridin-8-yl]benzoyl]amino]pentanedioic acid;sulfuric acid
InChi Key: GKJSPWCDMPVQHB-KZCZEQIWSA-N
InChi Code: InChI=1S/C20H23N7O6.H2O4S/c21-20-24-16-15(18(31)25-20)27-9-26(8-12(27)7-22-16)11-3-1-10(2-4-11)17(30)23-13(19(32)33)5-6-14(28)29;1-5(2,3)4/h1-4,12-13H,5-9H2,(H,23,30)(H,28,29)(H,32,33)(H4,21,22,24,25,31);(H2,1,2,3,4)/t12-,13+;/m1./s1
SMILES Code: O=C(O)[C@@H](NC(C1=CC=C(N2CN3C4=C(N=C(N)NC4=O)NC[C@]3([H])C2)C=C1)=O)CCC(O)=O.O=S(O)(O)=O
Appearance: To be determined
Purity: >98% (or refer to the Certificate of Analysis)
Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility: To be determined
Shelf Life: >2 years if stored properly
Drug Formulation: To be determined
Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code: 2934.99.9001
More Info:
| Biological target: | |
| In vitro activity: | |
| In vivo activity: |
The following data is based on the product molecular weight 555.52 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 1 mM | 1.15 mL | 5.76 mL | 11.51 mL |
| 5 mM | 0.23 mL | 1.15 mL | 2.3 mL |
| 10 mM | 0.12 mL | 0.58 mL | 1.15 mL |
| 50 mM | 0.02 mL | 0.12 mL | 0.23 mL |
| Formulation protocol: | |
| In vitro protocol: | |
| In vivo protocol: |
1: Glimelius B, Stintzing S, Marshall J, Yoshino T, de Gramont A. Metastatic
colorectal cancer: Advances in the folate-fluoropyrimidine chemotherapy
backbone. Cancer Treat Rev. 2021 Jul;98:102218. doi: 10.1016/j.ctrv.2021.102218.
Epub 2021 May 4. PMID: 34015686.
2: Carlsson G, Koumarianou A, Guren TK, Haux J, Katsaounis P, Kentepozidis N,
Pfeiffer P, Brændengen M, Mavroudis D, Taflin H, Skintemo L, Tell R,
Papadimitriou C. A phase I/II study of arfolitixorin and 5-fluorouracil in
combination with oxaliplatin (plus or minus bevacizumab) or irinotecan in
metastatic colorectal cancer. ESMO Open. 2022 Oct;7(5):100589. doi:
10.1016/j.esmoop.2022.100589. Epub 2022 Sep 29. PMID: 36183444; PMCID:
PMC9588906.
3: Taflin H, Odin E, Carlsson G, Tell R, Gustavsson B, Wettergren Y. Plasma
deoxyuridine as a surrogate marker for toxicity and early clinical response in
patients with metastatic colorectal cancer after 5-FU-based therapy in
combination with arfolitixorin. Cancer Chemother Pharmacol. 2021
Jan;87(1):31-41. doi: 10.1007/s00280-020-04173-2. Epub 2020 Oct 24. PMID:
33099678; PMCID: PMC7801297.
